We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at ...

Welcome to Eye on AI, with AI reporter Sharon Goldman. In this edition: The wild side of OpenClaw…Anthropic’s new $20 million ...

The unveiling of the Isomorphic Labs Drug Design Engine (IsoDDE) represents a fundamental shift from merely predicting the ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

The first battle is science and solving disease, Demis Hassabis told Fortune. Next is the energy crisis, traveling the stars ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Fortune Editor-in-Chief Alyson Shontell shares her interview with Google’s AI head. The big leadership story: AI is improving ...

The winners over the next five years” will be the companies that “fully integrate” artificial intelligence into drug development, said Takeda research chief Andy Plump.

Stocks notched their best day since May in the wake of a technology rout fueled by worries over the billions of dollars being ...

A renewed wave of dip buying spurred a rally in tech stocks in the wake of a rout fueled by worries over the billions of ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

The linguistic landscape of India is not a collection of neat, isolated boxes. It is a fluid, rhythmic blend where languages collide and merge in the middle of a single breath. For years, global ...